American Bio Medica Corporation
OTC: ABMC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jean Neff
- Employees
- 16
- Headquarters
- Kinderhook, United States
- IPO year
- 1997
- Market cap
- $4.8K
- Website
- https://www.abmc.com
Loading ABMC…
Loading profile data…Frequently asked questions about ABMC
What does American Bio Medica Corporation (ABMC) do?
American Bio Medica Corporation (ABMC) specializes in the development and distribution of lateral flow immunoassay tests, primarily designed for the rapid detection of drugs in both urine and oral fluid samples. Their extensive range of urine-based drug screening solutions includes the Rapid Drug Screen, capable of identifying between 2 and 10 s...
Where does ABMC trade?
American Bio Medica Corporation (ABMC) trades on the Other OTC.
What sector is ABMC in?
American Bio Medica Corporation (ABMC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of American Bio Medica Corporation?
Jean Neff is the chief executive officer of American Bio Medica Corporation (ABMC).
Where is American Bio Medica Corporation headquartered?
American Bio Medica Corporation is headquartered in United States.
Does ABMC pay a dividend?
American Bio Medica Corporation (ABMC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABMC go public?
American Bio Medica Corporation (ABMC) completed its initial public offering in 1997.